Sort
15,273 grants matching “antimicrobial resistance”
DEVELOPMENT OF BROAD SPECTRUM ANTIVIRALS
$2,098,226Matthew Duchars · Unither Virology, Llc · N01 · FY2014 · AI
Sexually Transmitted Infections Clinical Trials Group: Development and Validation of Diagnostic Tools for Drug Resistant STIs
$2,079,705Edward Hook · University Of Alabama At Birmingham · N01 · FY2018 · AI
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)
$2,074,220Stephen A Spector · University Of California, San Diego · UM1 · FY2017 · AI
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)
$2,074,220Stephen A Spector · University Of California, San Diego · UM1 · FY2016 · AI
Neuregulin-4: A Novel Therapy for Inflammatory Bowel Disease
$2,074,215Soumitra Ghosh · Avexegen Therapeutics, Inc. · R44 · FY2022 · DK
Autophagy-Inducting Peptides and Target Identification for Treatment of Viruses
$2,068,997Beth C Levine · Washington University · U19 · FY2018 · AI
Application of Genomic Approaches to Bacterial Pathogenesis and Mechanisms of Antimicrobial Resistance
$2,058,793John Dekker · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Early detection and inference for emerging infectious agents in data-sparse settings
$2,056,250Sen Pei · Columbia University Health Sciences · R35 · FY2025 · GM
EDGE CMT: Predicting bacteriophage susceptibility from Escherichia coli genotype
$2,055,157Adam P Arkin · University Of California-Berkeley · · FY2022 · BIO
Comprehensive Sickle Cell Center
$2,051,280St. Jude Children'S Research Hospital · U54 · FY2005 · HL
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)
$2,046,978Stephen A Spector · University Of California, San Diego · UM1 · FY2015 · AI
Vaccine and Treatment Evaluation Units
$2,044,564Nadine Georges Rouphael · Emory University · UM1 · FY2021 · AI
Collectins and Innate Defense against Inhaled Pathogens
$2,035,812Barbara A Seaton · Boston University Medical Campus · P01 · FY2009 · AI
Application of Genomic Approaches to Bacterial Pathogenesis and Mechanisms of Antimicrobial Resistance
$2,030,561John Dekker · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Novel antiobiotic development for biodefense
$2,028,893Michael E. Johnson · University Of Illinois At Chicago · U01 · FY2009 · AI
Conducting Communicable Disease Research in Kenya
$2,027,858M Kariuki Njenga · Washington State University · U01 · FY2016 · GH
Optimizing Lead Therapeutic Compounds Against Infectious Diseases
$2,015,511Michael J. Dawson · · N01 · FY2017 · AI
Microbial Pathogenesis and Host Inflammatory Responses
$2,012,133Mark S Smeltzer · Univ Of Arkansas For Med Scis · P20 · FY2015 · GM
Microbial Pathogenesis and Host Inflammatory Responses
$2,012,133Mark S Smeltzer · Univ Of Arkansas For Med Scis · P20 · FY2016 · GM
Microbial Pathogenesis and Host Inflammatory Responses
$2,012,133Mark S Smeltzer · Univ Of Arkansas For Med Scis · P20 · FY2014 · GM
Antibacterial Resistance Leadership Group (ARLG)
$2,000,000Vance G Fowler · Duke University · UM1 · FY2013 · AI
Systems Immunolobiology of Antibiotic-Persistent MRSA Infection
$1,999,922Michael R Yeaman · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · U01 · FY2016 · AI
Anthrax Immune Globulin to Prevent & Treat Anthrax: Advanced Product Development
$1,998,521Gary S Nabors · Emergent Product Development Gaithersbur · U01 · FY2006 · AI
Novel antiobiotic development for biodefense
$1,991,637Michael E. Johnson · University Of Illinois At Chicago · U01 · FY2010 · AI
Systems Biology Approach to Redefine Susceptibility Testing and Treatment of MDR Pathogens in the Context of Host Immunity
$1,989,374Bernhard O Palsson · University Of California, San Diego · U01 · FY2016 · AI